(E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)

C150H161N33O16S — CID 158049746

IUPAC(E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)
SMILESC=CC(=O)Nc1ccc(CC(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.C=CC(=O)Nc1ccc(CC(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.C=CC(=O)Nc1ccc(CS(=O)(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.CN(C)C/C=C/C(=O)CC1CCN(Cc2ccnc(C(=O)Cc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)CC1.CN(C)C/C=C/C(=O)NC1CCN(Cc2ccnc(C(=O)Cc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)C1
InChIInChI=1S/C36H43N7O3.C34H40N8O3.2C27H26N6O3.C26H26N6O4S/c1-41(2)13-3-4-30(44)20-27-10-14-42(15-11-27)24-28-9-12-37-33(21-28)34(45)22-26-5-7-29(8-6-26)32-23-31-35(40-32)38-25-39-36(31)43-16-18-46-19-17-43;1-40(2)12-3-4-32(44)38-27-10-13-41(22-27)21-25-9-11-35-30(18-25)31(43)19-24-5-7-26(8-6-24)29-20-28-33(39-29)36-23-37-34(28)42-14-16-45-17-15-42;2*1-2-25(35)31-21-8-7-20(28-16-21)14-22(34)13-18-3-5-19(6-4-18)24-15-23-26(32-24)29-17-30-27(23)33-9-11-36-12-10-33;1-2-24(33)30-20-7-8-21(27-14-20)16-37(34,35)15-18-3-5-19(6-4-18)23-13-22-25(31-23)28-17-29-26(22)32-9-11-36-12-10-32/h3-9,12,21,23,25,27H,10-11,13-20,22,24H2,1-2H3,(H,38,39,40);3-9,11,18,20,23,27H,10,12-17,19,21-22H2,1-2H3,(H,38,44)(H,36,37,39);2*2-8,15-17H,1,9-14H2,(H,31,35)(H,29,30,32);2-8,13-14,17H,1,9-12,15-16H2,(H,30,33)(H,28,29,31)/b2*4-3+;;;
InChIKeyFJIJWUOTOLNIHH-VVDZMTNVSA-N
MW2714.22 g/mol
LogP17.43
Rot. Bonds47

About (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)

(E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide) (PubChem CID 158049746) has the molecular formula C150H161N33O16S and a molecular weight of 2714.22 g/mol. Its IUPAC name is (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide).

Molecular Properties

Compound Name(E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)
PubChem CID158049746
Molecular FormulaC150H161N33O16S
Molecular Weight2714.22 g/mol
Exact Mass2712.25
IUPAC Name(E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)
SMILESC=CC(=O)Nc1ccc(CC(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.C=CC(=O)Nc1ccc(CC(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.C=CC(=O)Nc1ccc(CS(=O)(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.CN(C)C/C=C/C(=O)CC1CCN(Cc2ccnc(C(=O)Cc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)CC1.CN(C)C/C=C/C(=O)NC1CCN(Cc2ccnc(C(=O)Cc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)C1
InChIInChI=1S/C36H43N7O3.C34H40N8O3.2C27H26N6O3.C26H26N6O4S/c1-41(2)13-3-4-30(44)20-27-10-14-42(15-11-27)24-28-9-12-37-33(21-28)34(45)22-26-5-7-29(8-6-26)32-23-31-35(40-32)38-25-39-36(31)43-16-18-46-19-17-43;1-40(2)12-3-4-32(44)38-27-10-13-41(22-27)21-25-9-11-35-30(18-25)31(43)19-24-5-7-26(8-6-24)29-20-28-33(39-29)36-23-37-34(28)42-14-16-45-17-15-42;2*1-2-25(35)31-21-8-7-20(28-16-21)14-22(34)13-18-3-5-19(6-4-18)24-15-23-26(32-24)29-17-30-27(23)33-9-11-36-12-10-33;1-2-24(33)30-20-7-8-21(27-14-20)16-37(34,35)15-18-3-5-19(6-4-18)23-13-22-25(31-23)28-17-29-26(22)32-9-11-36-12-10-32/h3-9,12,21,23,25,27H,10-11,13-20,22,24H2,1-2H3,(H,38,39,40);3-9,11,18,20,23,27H,10,12-17,19,21-22H2,1-2H3,(H,38,44)(H,36,37,39);2*2-8,15-17H,1,9-14H2,(H,31,35)(H,29,30,32);2-8,13-14,17H,1,9-12,15-16H2,(H,30,33)(H,28,29,31)/b2*4-3+;;;
InChIKeyFJIJWUOTOLNIHH-VVDZMTNVSA-N
XLogP17.43
TPSA583.50 Ų
H-Bond Donors9
H-Bond Acceptors40
Rotatable Bonds47
Heavy Atoms200
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002714.22
LogP ≤ 517.43
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1040

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)?
The IUPAC name of (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide) (CID 158049746) is (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide).
What is the SMILES notation for (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)?
The canonical SMILES for (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide) is C=CC(=O)Nc1ccc(CC(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.C=CC(=O)Nc1ccc(CC(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.C=CC(=O)Nc1ccc(CS(=O)(=O)Cc2ccc(-c3cc4c(N5CCOCC5)ncnc4[nH]3)cc2)nc1.CN(C)C/C=C/C(=O)CC1CCN(Cc2ccnc(C(=O)Cc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)CC1.CN(C)C/C=C/C(=O)NC1CCN(Cc2ccnc(C(=O)Cc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)C1.
What is the InChIKey of (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)?
The InChIKey is FJIJWUOTOLNIHH-VVDZMTNVSA-N. The full InChI is InChI=1S/C36H43N7O3.C34H40N8O3.2C27H26N6O3.C26H26N6O4S/c1-41(2)13-3-4-30(44)20-27-10-14-42(15-11-27)24-28-9-12-37-33(21-28)34(45)22-26-5-7-29(8-6-26)32-23-31-35(40-32)38-25-39-36(31)43-16-18-46-19-17-43;1-40(2)12-3-4-32(44)38-27-10-13-41(22-27)21-25-9-11-35-30(18-25)31(43)19-24-5-7-26(8-6-24)29-20-28-33(39-29)36-23-37-34(28)42-14-16-45-17-15-42;2*1-2-25(35)31-21-8-7-20(28-16-21)14-22(34)13-18-3-5-19(6-4-18)24-15-23-26(32-24)29-17-30-27(23)33-9-11-36-12-10-33;1-2-24(33)30-20-7-8-21(27-14-20)16-37(34,35)15-18-3-5-19(6-4-18)23-13-22-25(31-23)28-17-29-26(22)32-9-11-36-12-10-32/h3-9,12,21,23,25,27H,10-11,13-20,22,24H2,1-2H3,(H,38,39,40);3-9,11,18,20,23,27H,10,12-17,19,21-22H2,1-2H3,(H,38,44)(H,36,37,39);2*2-8,15-17H,1,9-14H2,(H,31,35)(H,29,30,32);2-8,13-14,17H,1,9-12,15-16H2,(H,30,33)(H,28,29,31)/b2*4-3+;;;.
What are the key properties of (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide)?
(E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide) has a molecular weight of 2714.22 g/mol, XLogP of 17.43, 47 rotatable bonds, 9 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-5-(dimethylamino)-1-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]piperidin-4-yl]pent-3-en-2-one;(E)-4-(dimethylamino)-N-[1-[[2-[2-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]acetyl]-4-pyridinyl]methyl]pyrrolidin-3-yl]but-2-enamide;N-[6-[[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]methylsulfonylmethyl]-3-pyridinyl]prop-2-enamide;bis(N-[6-[3-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-2-oxopropyl]-3-pyridinyl]prop-2-enamide) is sourced from PubChem (CID 158049746), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).